Algorithm lowers number of CTs for some strokes

Publication
Article
Diagnostic Imaging EuropeDiagnostic Imaging Europe Vol 26 No 6
Volume 26
Issue 6

An imaging algorithm reduced the number of CT angiography and CT perfusion studies performed on patients with aneurysmal subarachnoid hemorrhages, a form of stroke.

An imaging algorithm reduced the number of CT angiography and CT perfusion studies performed on patients with aneurysmal subarachnoid hemorrhages, a form of stroke. The study was performed at New York Presbyterian Hospital – Weill Cornell Medical Center researchers and included 60 patients.

The algorithm identifies the most appropriate points at which to detect vasospasm with CT angiography and CT perfusion imaging. A flow chart establishes imaging pathways and time frames.

With the new algorithm, the mean number of CT examinations per patient dropped from 7.8 to 5.8, a decrease of 25.6%, according to the researchers. The number of CT perfusion exams per patient decreased 32.1% and overall cumulative radiation exposure decreased by 12.1%.

The results were published in the American Journal of Roentgenology (AJR 2010;195(1):176-180).

Recent Videos
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Related Content
© 2025 MJH Life Sciences

All rights reserved.